0001140361-17-046682.txt : 20171219 0001140361-17-046682.hdr.sgml : 20171219 20171219142800 ACCESSION NUMBER: 0001140361-17-046682 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171219 EFFECTIVENESS DATE: 20171219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XRad Therapeutics, Inc. CENTRAL INDEX KEY: 0001724308 IRS NUMBER: 812656148 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301137 FILM NUMBER: 171263693 BUSINESS ADDRESS: STREET 1: 7 ESSEX STREET #3B CITY: NEW YORK STATE: NY ZIP: 10002 BUSINESS PHONE: (917) 809-0858 MAIL ADDRESS: STREET 1: 7 ESSEX STREET #3B CITY: NEW YORK STATE: NY ZIP: 10002 D 1 primary_doc.xml X0708 D LIVE 0001724308 XRad Therapeutics, Inc. 7 ESSEX STREET #3B NEW YORK NY NEW YORK 10002 (917) 809-0858 DELAWARE None None Corporation true 2016 Anthony Y. Sun c/o XRad Therapeutics, Inc. ESSEX STREET #3B NEW YORK NY NEW YORK 10002 Executive Officer Director Michael Kastan c/o XRad Therapeutics, Inc. 7 ESSEX STREET #3B NEW YORK NY NEW YORK 10002 Director Biotechnology Decline to Disclose 06b false 2017-12-04 false true false 0 5498624 498624 5000000 false 1 0 0 0 false XRad Therapeutics, Inc. /s/ Anthony Y. Sun Anthony Y. Sun President 2017-12-19